A detailed history of Central Valley Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Central Valley Advisors, LLC holds 17,414 shares of MRK stock, worth $1.74 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares
17,414
Previous 16,916 2.94%
Holding current value
$1.74 Million
Previous $2.34 Billion 15.55%
% of portfolio
1.12%
Previous 1.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$111.15 - $128.97 $55,352 - $64,227
498 Added 2.94%
17,414 $1.98 Billion
Q2 2024

Jul 12, 2024

BUY
$123.8 - $132.96 $41,473 - $44,541
335 Added 2.02%
16,916 $2.34 Billion
Q1 2024

Apr 12, 2024

BUY
$113.24 - $131.95 $81,759 - $95,267
722 Added 4.55%
16,581 $2.19 Billion
Q4 2023

Feb 09, 2024

BUY
$100.18 - $109.02 $1.59 Million - $1.73 Million
15,859 New
15,859 $1.73 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Central Valley Advisors, LLC Portfolio

Follow Central Valley Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Valley Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Central Valley Advisors, LLC with notifications on news.